Tech Company Inital Public Offerings
Impel NeuroPharma IPO
Impel NeuroPharma was acquired by . Shares became public on 4/23/2021.
Transaction Overview
Company Name
Announced On
4/23/2021
Transaction Type
IPO
Amount
$79,500,000
Proceeds Purpose
Use of proceeds for the Impel NeuroPharma IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
201 Elliott Ave. West 260
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
Seattle-based Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jon Congleton
Chief Medical Officer
Stephen Shrewsbury
Chief Scientific Officer
John Hoekman
Vice President
Michael Malafronte
VP - Bus. Development
Ellen Lubman
VP - Engineering
Scott Youmans
VP - Operations
Meghan Swardstrom
VP - Regulatory Affairs
Lynn Gold
Browse more venture capital transactions:
Prev: 4/23/2021: Albedo venture capital transaction
Next: 4/23/2021: Percent venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs